Bio-Techne (TECH) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts TECH Hot Sheet
Join SI Premium – FREE
Bio-Techne (NASDAQ: TECH) reported Q4 EPS of $0.52, in-line with the analyst estimate of $0.52. Revenue for the quarter came in at $321.2 million versus the consensus estimate of $314.7 million.
For earnings history and earnings-related data on Bio-Techne (TECH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nelson Peltz Prepares Bid For Wendy’s - FT
- NeOnc Phase 2a brain cancer trial shows 48.9% survival vs. 20% benchmark
- Digital Brands Group forecasts positive cash flow starting in September
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
